Overview
- Attorney General James Uthmeier issued a Civil Investigative Demand on Tuesday that requires CVS Health and its Caremark PBM to produce thousands of documents by July 28, 2026.
- The CID asks for reimbursement rates, pharmacy contracts, records on patient steering, audit and clawback files, rebate data, and plans for retail expansion.
- Investigators are probing allegations that CVS/Caremark steered patients to CVS stores, paid affiliated pharmacies more than independents, used audits to recoup payments, and enforced restrictive contracts that squeeze small pharmacies.
- CVS said it will cooperate with the inquiry and disputed that PBMs are the main cause of high drug prices, arguing drugmakers set list prices while noting independent pharmacies remain part of its networks.
- The investigation comes as three large PBMs handle about 80% of U.S. prescriptions and could affect pharmacy access for seniors and low‑income Floridians if the probe finds practices that contributed to store closures.